Trials / Completed
CompletedNCT00973817
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Acute on Chronic Hepatitis
Efficacy and Safety of the Extracorporeal Liver Assist Device (ELAD) in Subjects With Acute On Chronic Hepatitis (AOCH)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- Vital Therapies, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 67 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety and efficacy of the use of ELAD in patients with diagnosed Acute On Chronic Hepatitis, including Acute Alcoholic Hepatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ELAD plus standard of care treatment | Use of ELAD plus standard of care |
| OTHER | Standard of care | Standard of care in the treatment of AOCH will be administered |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Completion
- 2011-05-01
- First posted
- 2009-09-09
- Last updated
- 2013-04-08
Locations
21 sites across 2 countries: United States, United Kingdom
Source: ClinicalTrials.gov record NCT00973817. Inclusion in this directory is not an endorsement.